Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 172

    1.

    Comparison of different techniques for purification of triamcinolone acetonide suspension for intravitreal use.

    García-Arumí J, Boixadera A, Giralt J, Martinez-Castillo V, Gomez-Ulla F, Corcostegui B, García-Arumí E.

    Br J Ophthalmol. 2005 Sep;89(9):1112-4.PMID: 16113361 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Removal of benzyl alcohol from a commercially available triamcinolone acetonide suspension for intravitreal use.

    Hernaez-Ortega MC, Soto-Pedre E.

    Ophthalmic Surg Lasers Imaging. 2006 Mar-Apr;37(2):162-4.PMID: 16583642 [PubMed - indexed for MEDLINE]Related articles

    3.

    Influence of different purification techniques on triamcinolone yield and particle size spectrum.

    Szurman P, Kaczmarek R, Jaissle GB, Grisanti S, Lüke M, Spitzer MS, Heide PE, Bartz-Schmidt KU.

    Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):689-96. Epub 2006 Sep 28.PMID: 17006679 [PubMed - indexed for MEDLINE]Related articles

    4.

    Isolating triamcinolone acetonide particles for intravitreal use with a porous membrane filter.

    Nishimura A, Kobayashi A, Segawa Y, Sakurai M, Shirao E, Shirao Y, Sugiyama K.

    Retina. 2003 Dec;23(6):777-9.PMID: 14707826 [PubMed - indexed for MEDLINE]Related articles

    5.

    Preservative-free triamcinolone acetonide suspension developed for intravitreal injection.

    Bitter C, Suter K, Figueiredo V, Pruente C, Hatz K, Surber C.

    J Ocul Pharmacol Ther. 2008 Feb;24(1):62-9.PMID: 18370876 [PubMed - indexed for MEDLINE]Related articles

    6.

    A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection.

    Hernaez-Ortega MC, Soto-Pedre E.

    Ophthalmic Surg Lasers Imaging. 2004 Jul-Aug;35(4):350-1.PMID: 15305565 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intravitreal injection of triamcinolone acetonide.

    Soto-Pedre E, Hernaez-Ortega MC.

    Acta Ophthalmol Scand. 2007 Mar;85(2):234; author reply 234-5. No abstract available. PMID: 17305752 [PubMed - indexed for MEDLINE]Related articles

    8.

    Triamcinolone acetonide concentration after filtration of the solvent agent.

    Spandau UH, Derse M, Schmitz-Valckenberg P, Papoulis C, Sagstetter BU, Stiefvater K, Jonas JB.

    Am J Ophthalmol. 2005 Apr;139(4):712-3.PMID: 15808171 [PubMed - indexed for MEDLINE]Related articles

    9.

    Purification of triamcinolone acetonide suspension for intravitreal injection.

    Soto-Pedre E.

    Br J Ophthalmol. 2006 Jan;90(1):123-4. No abstract available. PMID: 16361689 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Quantification of sedimented triamcinolone for intravitreal injection.

    Tsong JW, Persaud TO, Mansour SE.

    Retina. 2007 Nov-Dec;27(9):1255-9.PMID: 18046234 [PubMed - indexed for MEDLINE]Related articles

    11.

    Carboxymethylcellulose as a new carrier substance for intravitreal injection of reproducible amounts of triamcinolone.

    Kube T, Sutter M, Trittler R, Feltgen N, Hansen LL, Agostini HT.

    Graefes Arch Clin Exp Ophthalmol. 2006 Nov;244(11):1385-90. Epub 2006 May 20.PMID: 16715253 [PubMed - indexed for MEDLINE]Related articles

    12.

    Examination of purification methods and development of intravitreal injection of triamcinolone acetonide.

    Oishi M, Maeda S, Nakamura A, Kurokawa N, Ohguro N, Tano Y.

    Jpn J Ophthalmol. 2005 Sep-Oct;49(5):384-7.PMID: 16187038 [PubMed - indexed for MEDLINE]Related articles

    13.

    Measurement of the actual dose of triamcinolone acetonide delivered by common techniques of intravitreal injection.

    Ober MD, Barile GR, Tari SR, Tosi GM, Schiff WM, Chang S.

    Am J Ophthalmol. 2006 Oct;142(4):597-600. Erratum in: Am J Ophthalmol. 2007 Apr;143(4):736. Tossi, Gian M [corrected to Tosi, Gian Marco]. PMID: 17011851 [PubMed - indexed for MEDLINE]Related articles

    14.

    Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

    Jonas JB.

    Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. Review.PMID: 16396641 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits.

    Morrison VL, Koh HJ, Cheng L, Bessho K, Davidson MC, Freeman WR.

    Retina. 2006 Mar;26(3):339-44.PMID: 16508436 [PubMed - indexed for MEDLINE]Related articles

    16.

    Intravitreal triamcinolone acetonide concentration after subtenon injection.

    Thomas ER, Wang J, Ege E, Madsen R, Hainsworth DP.

    Am J Ophthalmol. 2006 Nov;142(5):860-1.PMID: 17056371 [PubMed - indexed for MEDLINE]Related articles

    17.

    In vitro benzyl alcohol cytotoxicity: implications for intravitreal use of triamcinolone acetonide.

    Chang YS, Wu CL, Tseng SH, Kuo PY, Tseng SY.

    Exp Eye Res. 2008 Jun;86(6):942-50. Epub 2008 Mar 16.PMID: 18420195 [PubMed - indexed for MEDLINE]Related articles

    18.

    Filter connected with three-way cock in remove of the vehicle in triamcinolone acetonide.

    Du L, Xing Y, Chen C.

    Yan Ke Xue Bao. 2006 Sep;22(3):156-9, 165.PMID: 17162900 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intravitreal triamcinolone acetonide: a change in a paradigm.

    Jonas JB.

    Ophthalmic Res. 2006;38(4):218-45. Epub 2006 Jun 6. Review.PMID: 16763379 [PubMed - indexed for MEDLINE]Related articles

    20.

    Retinal toxicity of triamcinolone's vehicle (benzyl alcohol): an electrophysiologic and electron microscopic study.

    Macky TA, Helmy D, El Shazly N.

    Graefes Arch Clin Exp Ophthalmol. 2007 Jun;245(6):817-24. Epub 2006 Nov 17.PMID: 17111149 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data